- Our Story
- Our Products
- Our Science
- Our People & Citizenship
-
Investors
- Reports and Filings
- Presentations & Earnings Calls
-
Shares
- Share Price
- Stock Updates
- Equity & Dividend History
- Unpaid & Unclaimed Dividend
- Analyst Coverage
- Shareholding Pattern
- Share Transfer Information
- Buyback
- Details of Shares for transfer to IEPF May 2018
- Notice pursuant to IEPF Rules, May 2018
- Details of Shares for transfer to IEPF May 2019
- Notice Pursuant to IEPF Rules, May 2019
- Details of Shares for transfer to IEPF May 2020
- Notice pursuant to IEPF Rules, May 2020
- Details of Shares for transfer to IEPF May 2021
- Notice pursuant to IEPF Rules, May 2021
- Governance
- Investor Services
-
ESG profile
- Media
- Partners
- Contact Us
Press Releases
Apr
Feb
- Binnopharm Group enters into agreement to acquire two anti-bacterial brands from Dr. Reddy’s in the Russia & CIS region
- Dr. Reddy's Laboratories enters into exclusive sales and distribution agreement with Novartis India Limited for select India brands
- Dr. Reddy's Laboratories announces the launch of its authorized generic version of VASOSTRICT® (vasopressin injection, USP) Vials in the U.S. Market
- Dr. Reddy’s Laboratories announces DCGI approval to the single-shot Sputnik Light vaccine in India
- Updates to the Press Release submitted on February 3, 2022
- Dr. Reddy's Laboratories enters into Definitive Agreement to acquire German medical cannabis firm Nimbus Health GmbH
- Dr. Reddy's included in S&P Global’s Sustainability Yearbook for the 2nd year and Bloomberg Gender-Equality Index for the 5th year in a row
- Akhil Ravi appointed CEO of Aurigene Pharmaceutical Services Ltd.
